Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18602726 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
Condition: Influenza
Interventions: Biological: CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free;   Biological: CSL Trivalent Inactivated Influenza Vaccine with Thimerosal;   Biological: Placebo with Thimerosal

Indicates status has not been verified in more than two years